Eric Lefkovsky – Making A Life-Changing Difference

Eric Lefkovsky is a Chicago billionaire, who wants to facilitate change about the way the medical community fights cancer. He launched Tempus Labs to enhance how cancer patients are diagnosed. Tempus is highly focused on the available data, and so is Lefkovsky. The company partners with premier institutions of higher learning, as well as NCI-designated cancer centers, to gather cancer patient data, They subsequently consolidate and organize it, so the information can be disseminated to doctors, who can use it to create treatment plans which are tailored specifically to each patient.

According to Lefkovsky, the best treatment approach utilizes both clinical data and the information in the patient’s health profile, which he cites as molecular data. He is referring to the patient’s genetic makeup (DNA and RNA). Ultimately, Tempus’ goal is to use the collected data in combination with science and technology advances, and human genome sequencing to promote improved cancer treatment.

Eric Lefkovsky is the co-founder of several companies, including Groupon, Uptake, Echo Global Logistics, Inner-Workings, and Lightbank. He is currently an adjunct professor at the University of Chicago’s Booth School of Business but formerly held teaching positions at the Kellogg School of Management at Northwestern University, and the Kellstadt Graduate School of Business at DePaul University.

He is an enthusiastic philanthropist. Eric and his wife founded the Lefkovsky Family Foundation, which is focused on the advance of “high-impact initiatives that enhance the quality of human life”. They promote these goals through donations in the areas of medicine, human rights, art and culture, and education. Eric and Liz are both members of The Giving Pledge. He is Chairman of the Board of Trustees for the Steppenwolf Theatre Company, based in Chicago. Lefkovsky is a board member of several organizations, which include the Lurie’s Children Hospital of Chicago, The Museum of Science and History, The Art Institute of Chicago, and World Business Chicago.

Eric Lefkovsky has personal and profiles on Facebook, Twitter, and LinkedIn. His social media profiles, especially his Twitter feed show where his interests lie. His focus is on cancer treatment and other organizations where he is involved.

Contact Eric Lefkovsky : www.facebook.com/eplefkofsky/

Dr. David Samadi’s SMART Technique

Dr. David B. Samadi is a certified urologist and he specializes in the diagnosis, analysis, and treatments of diseases such as kidney, prostate and bladder cancers as well as urologic diseases. He is the current urology chairman and chief of Robotic surgery at Lenox Hill Hospital. Dr. Samadi attended Stony Brook University where he graduated with a degree in biochemistry and later his M.D in 1994, later he went to Albert Einstein College of Medicine and Montefiore Medical Center for his postgraduate training. He did his fellowship in proctology at the Memorial Sloan Kettering Cancer Center. Dr. Samadi has enormous experience in his field and has worked in over 45 different countries and has practiced in every prestigious organization including Mt. Sinai School of Medicine, and Colombia Presbyterian Hospital. He is a member of the American Medical Association and the American Urological Association.

Dr. Samadi has dedicated is work to help men complete recovery after prostate cancer and improving their quality of life after the treatment. He therefore recently developed the Samadi Advanced Robotic Technique (SMART) which is a new and innovative way of surgically removing the cancerous prostate. This technique reduces surgical time to two hours and recovery hospital time to less than 24 hours. His new technique employs the use of advanced computer technology and robotics in the removal of the prostate. He has already performed over 7,000 successful surgeries using this technique. This technique reduces the risk of damaging tissues and nerves during surgery. This is because Dr. Samadi does not suture the dorsal vein complex or open the side of the prostate. The procedure is simple and is carried out through very small microscopic precisions therefore greatly reducing pain and bleeding.

After surgery, his patients have reported 85 percent sexual functions shortly after the surgery and 97 percent continence rate.Dr. David Samadi has taken an initiative to help men who suffer from prostate cancer avoid the negative effects of prostate surgery. He has taken an initiative to educate the general public about medical related issues such as research which features latest innovations in medical technologies, men-related health issues and alternative medication and treatment for prostate cancer through holding TV and radio talk shows. From 2011 to 2016, he was a host of the Sunday Housecall on Fox News Channel. On March 2015, he started a radio program and a blog website about health news. In 2012, Dr. Samadi was the highest paid doctor in New York earning over 7.5 million dollars.

Eric Lefkofsky’s Achievements

Eric Lefkofsky is the CEO and co-founder of Tempus, which is a technology company that has built a super operating system to be used in battling cancer. Eric is also a founding partner of Lightbank, a company that ventures in fund investment in matters to do with disruptive technologies. On the other hand, he is the chairman and co-founder of Groupon, an e-commerce marketplace globally as well as a co-founder of Uptake Technologies. Uptake Technologies is one of the world’s largest industries in predicting analytics platform. Echo Global Logistics is a logistic outsourcing and technology-enabled transportation firm, and Inner Workings is a provider of managed promotional and print solutions globally.

Tempus mission is to redefine the way genomic data is used and applied in a clinical setting. The company’s major goal is to ensure that each and every patient benefits fully from the treatment of those individuals who come before by ensuring they provide physicians with the adequate tools that learn and gather more data. Also, the company provides transcriptomic and genomic services and analyzes germline and somatic molecular data along with therapeutical data to ensure they empower physicians to make a compelling data-driven decision.

In the year 2006, Lefkofsky together with his wife formed a charitable trust by the name Lefkofsky Family Foundation. Its mission is to support charitable and educational organizations, scientific and causes around the entire world. The Foundation’s primary purpose is to ensure that advance initiatives and high impact programs can improve the living standards of human life in the communities. The foundation focuses on human rights, education, arts and culture, and medical research. The grant making is always evaluated quarterly, and higher part of the money is focused on Chicago which is Lefkofskys’ hometown, whereby arts and culture take the largest donations.

Eric’s education support initiative focuses on Greater Chicago area where they engage in helping younger children as well as giving charters to schools, scholarship programs and after-school programs for the disadvantaged youth. The foundation also engages in supporting medical centers particularly those that care for children as well as give donations to pancreatic cancer. Also, Lefkofskys has supported research in the treatment as well as the cure for lung cancer, thyroid cancer, and leukemia. The foundation has also partnered with Motorola Mobility and Google to create 1871 FEMtech, with the hope and goal of enabling and encouraging more female tech to break into the field as entrepreneurs.